# Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-nivolumab-plus-ipilimumab-in-resectable-non-small-cell-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Joshua E. Reuss,Valsamo Anagnostou,Tricia R. Cottrell,Kellie N. Smith,Franco Verde,Marianna Zahurak,Mara Lanis,Joseph C. Murray,Hok Yee Chan,Caroline G. McCarthy,Daphne Wang,James R. White,Stephen C. Yang,Richard J. Battafarano,Stephen Broderick,Errol L. Bush,Malcolm V. Brock,Jinny S. Ha,David R. Jones,Taha Merghoub,Janis M. Taube,Victor E. Velculescu,Gary L. Rosner,Peter B. Illei,Drew M. Pardoll,Suzanne L. Topalian,Jarushka Naidoo,B.I. Levy,Matthew D. Hellmann,Julie R. Brahmer,Jamie E. Chaft,Patrick M. Forde |
| Citations | 166 |
| DOI | 10.1136/jitc-2020-001282 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jitc.bmj.com/content/jitc/8/2/e001282.full.pdf |
| OpenAlex ID | https://openalex.org/W3086555948 |
| PMID | 32929052 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Julie R. Brahmer](https://scholariq.org/researchers/julie-r-brahmer/)
- [Matthew D. Hellmann](https://scholariq.org/researchers/matthew-d-hellmann/)
- [Peter B. Illei](https://scholariq.org/researchers/peter-b-illei/)
- [Errol L. Bush](https://scholariq.org/researchers/errol-l-bush/)
- [Patrick M. Forde](https://scholariq.org/researchers/patrick-m-forde/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.